2.1. Fruit material
Fruits of India hog plum (Spondias mangifera Willd.) fruits were obtained from the local market. These fruits were washed thoroughly to remove dirt and debris followed by slicing and dried at 50°C for 72 hours in a hot air oven and powdered to 60 mesh in a grinder (Apex Constructions, London).
2.2. Chemicals
HPLC grade Methanol, solvents like Hexane, Chloroform, Ethyl acetate and Methanol were obtained by Merck Limited, Mumbai. Silica gel (60-100 mesh and 100-200) was obtained from Qualigens Fine Chemicals, Mumbai. BHA, 1, 1-diphenyl-2-picryl-hydrazyl (DPPH), nicotinamide adenine dinucleotide (NADH) Trichloroaceticand acid (TCA) were purchased from Sigma (Sigma-Aldrich GmbH, Germany). Potassium ferricyanide, Ferrozine and Ferric Chloride were purchased from M/s Sisco Research Laboratories, Mumbai. Nitro blue tetrazolium (NBT), Phenazine methosulphate (PMS), Thiobarbituric acid (TBA) and Ethylene Diamine Tetra-Acetic acid (EDTA) were purchased from M/s Sigma Chemicals Co. (St. Louis, MO). Nutrient agar and Nutrient broth were obtained from HiMedia Laboratories Limited, Mumbai.
2.3 Platelet preparation
Samples were procured from healthy volunteers with substantial assurance that they were not administered any drugs during the two week period, prior to blood sampling. Blood was collected in buffered sodium citrate (3.8 % w/v), which is an anticoagulant with pH 6.5 at a ratio of 9:1 v/v and used within 3 hours of collection. Citrated blood was centrifuged at 1100 rpm for 20 min to produce platelet-rich plasma (PRP). Platelet-poor plasma (PPP) was obtained by centrifuging the residual blood at 2500 rpm for 20 min. Platelet count was adjusted to 1.6 x 107 platelets per ml of PRP.
2.4 Bacterial strains and inoculum preparation
The bacterial strains viz., Pseudomonas aeruginosa, Escherichia coli, Salmonella typhi, Klebsiella pneumoniae, Enterobacter aerogenes, Proteus mirabilis, Yersinia enterocolitica, Micrococcus luteus, Staphylococcus aureus, Enterococcus fecalis, Bacillus subtilis, Bacillus cereus and Listeria monocytogenes, isolated from clinical samples were procuredfrom the Department of Microbiology, Mysore Medical College, Mysore, India. The antibacterial activity was tested against these microbes. Their morphological features and cultural characteristics were confirmed and also subjected to standard biochemical tests before experimentation (Krieg and Holt, 1984; Sneath et al., 1986). The test organisms were maintained on nutrient agar slants.
2.5. Isolation of bioactive compound from methanol extract
2.5.1. Preparation of extracts
Sequential extraction was executed using solvents of different polarities (from non-polar to polar). The compounds of different polarities were effectively and completely resolved using sequential extraction. About 100 g of different fruit powder was sequentially extracted using n-hexane, followed by chloroform, ethyl acetate, acetone and methanol at room temperature (25±2°C), at normal atmospheric pressure, by shaking at 100 rpm for 48 hrs. Each extract was filtered and concentrated by using a rotary evaporator (Buchi Rotavapor R-124, Switzerland). The concentrated extracts were freeze-dried and stored in a refrigerator until use. The antioxidant activity of methanol extract was very assuring and motivated for the isolation and purification the antioxidant compound from it.
2.5.2. Fractionation of the methanol extract
A glass column (450 x 450mm) was packed with activated silica gel (60-120 mesh) using n-hexane solvent. For large scale isolation of antioxidant compound, about 12 g of crude methanol extract was loaded and eluted stepwise with 500 ml of hexane, 500 ml of chloroform, 2000 ml of chloroform: ethyl acetate (90:10 to 0: 100, v/v) and 2500 ml of ethyl acetate: methanol (90: 10 to 0: 100, v/v). About 22 fractions measuring 250 ml each were collected and concentrated by using the rotary evaporator.
2.5.3. Thin Layer Chromatography (TLC)
Thin layer chromatography technique was used to isolate the volatile compounds. Aliquots of each concentrated fraction were loaded on the activated silica gel TLC plates (20 x 20 cm). The plates were developed using the following ratios viz., chloroform: ethyl acetate (80:20), chloroform: ethyl acetate (60:40), chloroform: ethyl acetate (50:50), chloroform: ethyl acetate (30:70), chloroform: ethyl acetate (25:75) and chloroform: ethyl acetate: methanol (15:75:10) solvents. TLC plates with the spots were located by exposing the plate to iodine fumes. Fractions were pooled into seven fractions (Fr.1- Fr.7) Rf values. Among the seven fractions, five fractions (Fr. 3 – Fr. 7) tested showed antioxidant activity.
2.5.4. Further purification of bioactive fraction
Antioxidant activity guided column chromatography was carried out for further purification of fraction 7 (Fr. 7). Eluting 3.60 g of Fr. 7 by 100 ml of chloroform followed by 1000 ml of chloroform: ethyl acetate (95:5 to 0: 100, v/v) and by 300 ml of ethyl acetate: methanol (90:10 to 0: 100, v/v) through 100-200 mesh silica gel with 450 x 20 mm column yielded 15 fractions of 100 ml each. These fractions were concentrated by a rotary evaporator for further loading of these aliquots on the TLC plates. Based on the Rf value, these fractions were pooled into five fractions (Fr. 7.1 – Fr. 7.5). These fractions were tested for antioxidant activity (Fig. 2c). Among these five factions, fraction 7.4 (Fr. 7.4) exhibited the highest antioxidant activity. Eluting 874 g of Fr. 7.4 with 100 ml of chloroform: ethyl acetate (90: 10 to 0: 100, v/v) followed by 400 ml ofethyl acetate: acetone (90: 10 to 0: 100 v/v) and 200 ml of acetone: methanol (90: 10to 0: 100, v/v) through100-200 mesh silica gel with 600 x 15 mm column yielded 20 fractions of 50 ml each. These fractions were concentrated by a rotary evaporator for further loading of these aliquots on the TLC plates. Based on the Rf value, these fractions were pooled into four fractions (Fr. 7.4.1 – Fr. 7.4.4).
Among these, sub-fraction three (Fr.7.4.3) obtained from third chromatographic step showed a single spot on TLC. This pure compound was subjected to various spectroscopic techniques for elucidation of the structure.
2.3.4. High performance liquid chromatography (HPLC)
The purified compound was tested for its purity using HPLC, using LC-10AT liquid chromatograph (Shimadzu, Singapore) equipped with C-18 column (300 x 4.6 mm, 5 m Thermo Hypersil) and methanol: water (60: 40) as a mobile phase with a flow rate of one ml min-1. UV detection was carried out with a diode array detector (Shimadzu, Singapore).
2.4. Identification of bioactive compound
2.4.1. UV-Vis spectrophotometry
UV-Visible spectrum of the isolated compound was recorded on a Shimadzu UV-160A instrument (Shimadzu, Singapore) at room temperature. About 1 mg of isolated compound dissolved in 20 ml of methanol was used to record the spectrum (from 200-800 nm).
2.4.2. IR spectrometry
IR spectrum of isolated compound was recorded on a Perkin-Elmer FT-IR Spectrometer (Spectrum 2000) at room temperature. About 1 mg of isolated compound dissolved in 10 ml of DMSO was used to record the spectrum (frequencies between 4000 and 400 cm-1).
2.4.3. Liquid chromatography- Mass spectrometry (LC-MS)
Mass spectrum of the isolated compound was recorded on instrument HP 1100 MSD series (Palo Alto, CA) by electro spray ionization (ESI) technique with a flow rate of 0.2 ml min-1 on C-18 column and total run time of 40 min. Diode array was used as a detector. About 1 mg of isolated compound dissolved in five ml of methanol was used for recording the spectrum.
2.4.4. Two-Dimensional Heteronuclear Multiple Quantum Coherence Transfer Spectroscopy (2D-HMQCT) NMR spectra
NMR spectra were recorded on a Bruker DRX 500 NMR instrument (Rheinstetten, Germany) operating at 500 MHz for 1H and 125 MHz for 13C at room temperature. A region from 0-12 ppm for 1H and 0-200 ppm for 13C was employed. Signals were referred to internal standard tetramethylsilane. About 45 mg of isolated compound dissolved in 0.75 ml of DMSO was used for recording the spectra.
2.5. Antioxidant activity
2.5.1. DPPH free radical scavenging activity
DPPH (1, 1-diphenyl-2-picrylhydrazyl) radical scavenging activity was determined according to the method described earlier (Blois, 1958; Bondet et al., 1997; Moon and Terao, 1998). The test samples (10- 100 ml) were mixed with 0.8 ml of Tris-HCl buffer (pH 7.4) to which 1 ml of DPPH (500 mM in ethanol) was added. The mixture was shaken vigorously and left to stand for 30 min. Absorbance of the resulting solution was measured at 517 nm in a UV-Visible Spectrophotometer (UV-160A, Shimadzu co. Japan). The radical scavenging activity was measured as a decrease in the absorbance of DPPH. Lower absorbance of the reaction mixture indicated higher free radical scavenging activity. Radical scavenging potential was expressed as EC50 value, which represents the sample concentration at which 50 % of the DPPH radicals scavenged.
2.5.2. Super oxide radical scavenging activity
The super oxide scavenging ability was assessed according to the method of Nishikimi, Rao, Yagi, (Nishikimi et al., 1972) with slight modifications. The reaction mixture contained NBT (0.1 mM) and NADH (0.1 mM) with or without sample to be assayed in a total volume of 1 ml of Tris-HCl buffer (0.02 M, pH 8.3). The reaction was started by adding PMS (10 mM) to the mixture, and change in the absorbance was recorded at 560 nm every 30 seconds for 2 min. The percent inhibition was calculated against a control without test sample. Radical scavenging potential was expressed as EC50 value, which represents the sample concentration at which 50 % of the radicals scavenged.
2.5.3. Lipid peroxidation inhibitory activity
Lipid peroxidation inhibitory activity was determined according to the method described earlier (Duh et al., 1999). In brief, egg lecithin (3 mg/ml phosphate buffer, pH 7.4) was sonicated in dr. Hielscher GmbH, UP 50H ultraschallprozessor (DrHielscher GmbH, Teltow, Berlin, Germany). The test samples (100 ml) were added to 1ml of liposome mixture, control was without test sample. Lipid peroxidation was induced by adding 10 ml FeCl3 (400 mM) and 10 ml L-ascorbic acid (400 mM). After incubation for 1 hour at 37°C, the reaction was stopped by adding 2 ml of 0.25 N HCl containing 15 % TCA and 0.375 % TBA and the reaction mixture was boiled for 15 min. then cooled, centrifuged and absorbance of the supernatant was measured at 532 nm. Inhibitory activity was expressed as EC50 value, which is sample concentration inhibited 50 % of lipid peroxidation.
2.5.4. Metal chelating activity
The chelation of ferrous ions by the test sample was estimated by the method described earlier (Decker and Welch, 1990; Dinis et al. 1994). Briefly, the test samples at different concentrations were added to a solution of 2 mM FeCl2 (0.05 ml). The reaction was initiated by the addition of 5 mM ferrozine (0.2 ml) and the mixture was vigorously shaken and left standing at room temperature for 10 min. After the mixture had reached equilibrium, the absorbance of the mixture was read at 562 nm against a blank. EDTA was used as positive control. Results were expressed as EC50 value, which represents the sample concentration at which 50 % of metal chelation occurred.
2.6. Platelet-aggregation inhibitory activity
Aggregation was measured turbidimetrically at 37°C with constant stirring at 1000 rpm in a Chronolog Dual Channel Aggregometer. About 0.45 ml of PRP was kept stirred at 1200 rpm at 37°C, and aggregation was induced by collagen (10 mM) and ADP (10 mM). The change in turbidity was recorded with reference to PPP using an omniscribe recorder for at least 5 min. The slope was calculated and it was used as control. Similarly, 100-500 mM of the differentfruit extracts and isolated bioactive compounds were added to PRP, incubated for five min after which collagen (10 mM), was added. Platelet aggregation was recorded using an omniscribe recorder for 5 min. The slope was calculated. The difference in the slope between the control and the treated was expressed as percent inhibition of platelet aggregation by differentextracts.
2.7. Antibacterial activity
2.7.1. Minimum inhibitory concentration (MIC)
The minimal inhibitory concentration was determined according to the method described by Jones et al., 1985. A separate concentrate (20 ppm to 300 ppm) of a separate compound and 100 ofl bacterial suspension (105 CFU / ml) was applied aseptically in10 ml of the distinct broth and incubated. -24 h at 37 ° C. Growth was observed both by observation and by measurement O.D. at 600 nm at normal times followed by plating installation. The beating was performed by transferring the bacterial suspension (105 CFU / ml) to a sterile Petri plate and combined with a Nuttenent agar medium (HiMedia Laboratories Limited, Mumbai, India) was approved for intensification. Low concentration of the experimental sample that did not show significant growth was recorded as low inhibitory concentration. Three tube settings are kept in the test for each test sample. Amoxicillin (100 µg / mL) has been used as a positive control.
The minimum inhibitory concentration was determined according to the method described by Jones et al., 1985. Different concentrations (20 ppm to 300 ppm) of isolated compound and 100 ml of the bacterial suspension (105 CFU/ml) was placed aseptically in10 ml of nutrient broth separately and incubated at 37°C for 24 h. The growth was observed visually and measuring O.D. at 600 nm followed by pour plating. The plating was carried out by transferring bacterial suspension (105 CFU/ml) to sterile petri plate and mixed with molten nutrient agar medium and allowed to solidify. The test sample with least concentration without visible growth was considered as the minimum inhibitory concentration. Three sets of tubes were maintained for each concentration of test sample. Amoxicillin (100 µg/mL) was used as a positive control.
2.7. Statistical Analysis
The experiments were carried out in triplicates. Significant differences (P < 0.05) were determined by Duncan’s Multiple Range Test (DMRT).